OTCMKTS:PHGUF Pharming Group (PHGUF) Stock Forecast, Price & News $1.25 0.00 (0.00%) (As of 05/26/2023 ET) Add Compare Share Share Today's Range$1.25▼$1.2550-Day Range$1.03▼$1.5152-Week Range$0.77▼$1.59VolumeN/AAverage Volume60 shsMarket Capitalization$813.88 millionP/E Ratio31.20Dividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsHeadlinesShort InterestProfileChartCompetitorsEarningsHeadlinesShort Interest About Pharming Group (OTCMKTS:PHGUF) StockPharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.Read More Receive PHGUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. Email Address PHGUF Stock News HeadlinesMay 15, 2023 | markets.businessinsider.comRBC Capital Sticks to Their Buy Rating for Pharming Group (PHGUF)May 12, 2023 | msn.comPharming Group N.V. GAAP EPS of $0.02, revenue of $42.5M misses by $6MMay 28, 2023 | Stocks To Trade (Ad)Free A.I. Trade Alerts. Up to 15 opportunities a day.Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 11, 2023 | benzinga.comPharming Group shares are trading lower after the company reported a year-over-year decrease in Q1 EPS and revenue.May 11, 2023 | markets.businessinsider.comPharming Group NV American Depositary Shares Repr 10 earnings: here's what Wall Street expectsMay 11, 2023 | finance.yahoo.comPharming Group reports financial results for the first quarter of 2023May 8, 2023 | finance.yahoo.comPharming Group's (AMS:PHARM) investors will be pleased with their decent 51% return over the last yearApril 30, 2023 | americanbankingnews.comPharming Group (OTCMKTS:PHGUF) Short Interest Up 22.8% in AprilMay 28, 2023 | Behind the Markets (Ad)"Chilling War Games Show US Forces Crushed" – FOX NEWS=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>April 26, 2023 | finanznachrichten.dePharming Group N.V.: Pharming to attend the H.C. Wainwright BioConnect Investor Conference 2023April 26, 2023 | finance.yahoo.comPharming to attend the H.C. Wainwright BioConnect Investor Conference 2023April 19, 2023 | finanznachrichten.dePharming Group: Pharming to attend the Van Lanschot Kempen Life Sciences Conference 2023April 19, 2023 | finanznachrichten.dePharming Group N.V.: Notice of First Quarter 2023 ResultsApril 19, 2023 | finance.yahoo.comNotice of First Quarter 2023 ResultsApril 19, 2023 | finance.yahoo.comPharming to attend the Van Lanschot Kempen Life Sciences Conference 2023April 11, 2023 | finance.yahoo.comPharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.April 5, 2023 | finance.yahoo.comPharming Group announces the filing of its 2022 Annual Report and Form 20-FMarch 30, 2023 | finance.yahoo.comPharming to present at the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease DaysMarch 27, 2023 | finance.yahoo.comFDA Approves Pharming's Immune Disorder Drug, As First APDS TherapyMarch 13, 2023 | finance.yahoo.comPharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcementFebruary 28, 2023 | finanznachrichten.dePharming Group N.V.: Notice of Full Year 2022 financial resultsFebruary 28, 2023 | finance.yahoo.comNotice of Full Year 2022 financial resultsFebruary 21, 2023 | finanznachrichten.dePharming Group N.V.: Pharming announces first patient enrolled in pediatric clinical trial of leniolisibJanuary 9, 2023 | finance.yahoo.comPharming Group N.V.'s (AMS:PHARM) Intrinsic Value Is Potentially 49% Above Its Share PriceDecember 19, 2022 | finance.yahoo.comPharming Group N.V.'s (AMS:PHARM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?December 15, 2022 | finance.yahoo.comPharming Highlights Interim Data From Rare Immune Deficiency StudyDecember 15, 2022 | finance.yahoo.comPharming announces positive interim analysis data from open-label extension study of leniolisib in presentation at the 64th American Society of Hematology (ASH) Annual Meeting and ExpositionSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive PHGUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. Email Address PHGUF Company Calendar Last Earnings3/05/2015Today5/28/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PHGUF Previous SymbolOTC:PHGUF CUSIPN/A CIKN/A Webwww.pharming.com Phone(171) 524-7400Fax31-0-71-524-7445Employees277Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.04 Trailing P/E Ratio31.20 Forward P/E RatioN/A P/E GrowthN/ANet Income$16 million Net Margins14.90% Pretax MarginN/A Return on Equity15.52% Return on Assets7.77% Debt Debt-to-Equity Ratio0.68 Current Ratio5.40 Quick Ratio4.68 Sales & Book Value Annual Sales$198.87 million Price / Sales4.09 Cash Flow$0.06 per share Price / Cash Flow21.93 Book Value$0.31 per share Price / Book4.02Miscellaneous Outstanding Shares652,410,000Free FloatN/AMarket Cap$813.88 million OptionableNot Optionable Beta1.09 Key ExecutivesSijmen de VriesChief Executive Officer & Executive DirectorMireille SandersChief Operations OfficerJeroen Henk WakkermanChief Financial OfficerRobert FriesenChief Scientific OfficerAnurag RelanChief Medical OfficerKey CompetitorsArdelyxNASDAQ:ARDXBioXcel TherapeuticsNASDAQ:BTAIArcturus TherapeuticsNASDAQ:ARCTARS PharmaceuticalsNASDAQ:SPRYDyne TherapeuticsNASDAQ:DYNView All Competitors PHGUF Stock - Frequently Asked Questions How have PHGUF shares performed in 2023? Pharming Group's stock was trading at $1.1499 on January 1st, 2023. Since then, PHGUF stock has increased by 8.5% and is now trading at $1.2475. View the best growth stocks for 2023 here. Are investors shorting Pharming Group? Pharming Group saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 6,456,400 shares, an increase of 38.0% from the April 15th total of 4,679,100 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 64,564.0 days. View Pharming Group's Short Interest. How were Pharming Group's earnings last quarter? Pharming Group (OTCMKTS:PHGUF) announced its quarterly earnings data on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.01. Pharming Group had a trailing twelve-month return on equity of 15.52% and a net margin of 14.90%. What is Pharming Group's stock symbol? Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF." How do I buy shares of Pharming Group? Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Pharming Group's stock price today? One share of PHGUF stock can currently be purchased for approximately $1.25. How much money does Pharming Group make? Pharming Group (OTCMKTS:PHGUF) has a market capitalization of $813.88 million and generates $198.87 million in revenue each year. The biotechnology company earns $16 million in net income (profit) each year or $0.04 on an earnings per share basis. How many employees does Pharming Group have? The company employs 277 workers across the globe. How can I contact Pharming Group? Pharming Group's mailing address is Darwinweg 24, Leiden P7, 2333 CR. The official website for the company is www.pharming.com. The biotechnology company can be reached via phone at (171) 524-7400, via email at investor@pharming.com, or via fax at 31-0-71-524-7445. This page (OTCMKTS:PHGUF) was last updated on 5/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.